Oncology & Hematology Clinical Trial Development

About Oncology Clinical Trials

Clinical trials for targeted oncology and hematology therapies have become incredibly complex in the world of precision medicine. Whether you need support with early phase adaptive trial design, site selection, patient identification or targeted services for late-phase oncology trials, trust the expertise of a proven CRO who can help you to improve health and lives by bringing your oncology treatment to market quickly and carefully.

With our integrated oncology team, you have a committed partner with expertise and experience across diagnostics and drug development to urgently deliver the best trial that fits your business and strategy. A partner uniquely set up to efficiently bridge preclinical studies into human trials. A partner that can find the right patients and sites, understand your data and unique needs, and provide a customized strategy and successful execution plan to quickly and safely deliver your drug to the patients who greatly need life-improving and life-saving oncology treatments.

When you partner with us, you can be confident your trial is in the hands of oncology experts who have the passion, commitment and drive to find better answers for patients, now.

• More than 1035 early and late-stage oncology and hematology clinical trial studies in the past 5 years helping you to efficiently bridge preclinical studies to cancer patient trials.

• More than 300 immuno-oncology studies, including innovative CAR T therapies and adaptive trial designs.

• Co-development of drugs with an oncology companion diagnostic to help identify patients most likely to benefit from your next cancer breakthrough.

• Dedicated team of pediatric oncologists and rare disease specialists to help you navigate a complex regulatory environment while creating a truly patient centric trial approach that reduces the burden on sites and patients.